Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Teladoc Health, Inc.
Report date December 01, 2023 · Filed December 05, 2023
Section 16 reporting ended · disclosed 2023-12-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,703 |
Ending reported balance
After 2023-12-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-12-01 · Exercise / conversion · Acquired 2,807 · Balance 18,660 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2023-12-01 · Exercise / conversion · Acquired 2,043 · Balance 20,703 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,038 |
Reported balance
After 2023-12-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-12-01 · Exercise / conversion · Disposed 2,807 · Balance 14,038 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,264 |
Reported balance
After 2023-12-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-12-01 · Exercise / conversion · Disposed 2,043 · Balance 12,264 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3: On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F3: On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2023 Filed Dec 5, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000107 · wk-form4_1701810473.xml · derivative · entry 4 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,264 Underlying: Common Stock · 2,043 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000107 · wk-form4_1701810473.xml · derivative · entry 3 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,038 Underlying: Common Stock · 2,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,043 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000107 · wk-form4_1701810473.xml · nonDerivative · entry 2 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000107 · wk-form4_1701810473.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,093 | $22.89 | $47,917.14 |
DisclosureSEC source: 0001477449-23-000039 · wk-form4_1694031141.xml · nonDerivative · entry 3 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,853 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000039 · wk-form4_1694031141.xml · derivative · entry 5 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,307 Underlying: Common Stock · 2,043 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000039 · wk-form4_1694031141.xml · derivative · entry 4 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,845 Underlying: Common Stock · 2,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,043 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000039 · wk-form4_1694031141.xml · nonDerivative · entry 2 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000039 · wk-form4_1694031141.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| July 26, 2023 Filed Jul 27, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,547 | $29.00 | $189,863.00 |
DisclosureSEC source: 0001477449-23-000010 · wk-form4_1690488366.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,096 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 28, 2023. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,547 | $27.00 | $176,769.00 |
DisclosureSEC source: 0001477449-23-000002 · wk-form4_1689797172.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,643 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 28, 2023. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,635 | $24.38 | $113,005.94 |
DisclosureSEC source: 0001415889-23-009193 · form4-06052023_080628.xml · nonDerivative · entry 3 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,190 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 8,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009193 · form4-06052023_080628.xml · derivative · entry 5 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,350 Underlying: Common Stock · 8,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009193 · form4-06052023_080628.xml · derivative · entry 4 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,652 Underlying: Common Stock · 2,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 8,175 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-009193 · form4-06052023_080628.xml · nonDerivative · entry 2 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-009193 · form4-06052023_080628.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,888 | $24.44 | $70,579.83 |
DisclosureSEC source: 0001415889-23-008701 · form4-05242023_080506.xml · nonDerivative · entry 2 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,843 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit awards. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 9,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008701 · form4-05242023_080506.xml · derivative · entry 4 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,191 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On May 22, 2023, the reporting person earned 9,191 performance stock units, vesting on May 22, 2023. F6 · derivative.expiration_date: On May 22, 2023, the reporting person earned 9,191 performance stock units, vesting on May 22, 2023. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 9,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008701 · form4-05242023_080506.xml · derivative · entry 3 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,191 Underlying: Common Stock · 9,191 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F4 · shares: Performance award amount determined based on the achievement of certain research and development targets over a two-year performance period. F5 · derivative.exercise_date: The performance stock units vested on May 22, 2023. F5 · derivative.expiration_date: The performance stock units vested on May 22, 2023. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,191 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-008701 · form4-05242023_080506.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,699 | $25.64 | $43,565.76 |
DisclosureSEC source: 0001415889-23-007439 · form4-05052023_080505.xml · nonDerivative · entry 2 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,540 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007439 · form4-05052023_080505.xml · derivative · entry 3 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,617 Underlying: Common Stock · 5,616 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On May 3, 2021, the reporting person was granted 16,849 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On May 3, 2021, the reporting person was granted 16,849 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-007439 · form4-05052023_080505.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 37,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004407 · form4-03072023_090318.xml · derivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,202 Underlying: Common Stock · 37,202 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,388 | $25.36 | $85,926.46 |
DisclosureSEC source: 0001415889-23-004109 · form4-03032023_090316.xml · nonDerivative · entry 2 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,623 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 11,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004109 · form4-03032023_090316.xml · derivative · entry 3 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,459 Underlying: Common Stock · 11,229 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:19 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 11,229 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004109 · form4-03032023_090316.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 891 | $29.00 | $25,839.00 |
DisclosureSEC source: 0001415889-22-012042 · form4-12052022_091211.xml · nonDerivative · entry 2 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,782 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on October 31, 2022. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 892 | $28.72 | $25,618.24 |
DisclosureSEC source: 0001415889-22-012042 · form4-12052022_091211.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,673 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on October 31, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 24,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006081 · form4-06032022_010627.xml · derivative · entry 2 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,525 Underlying: Common Stock · 24,525 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: One-third of the restricted stock units vest on June 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: One-third of the restricted stock units vest on June 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 117,564 | $0.00 Strike: $32.62 | $0.00 |
DisclosureSEC source: 0001415889-22-006081 · form4-06032022_010627.xml · derivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,564 Underlying: Common Stock · 117,564 shares Expires 2032-05-31 F1 · derivative.exercise_date: The option will vest as to one-third of the shares on June 1, 2023. The remainder of the shares will vest in 24 substantially equal monthly installments thereafter. Read SEC document |
| May 04, 2022 Filed May 5, 2022 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,051 | $37.85 | $77,620.10 |
DisclosureSEC source: 0001415889-22-004664 · form4-05052022_010503.xml · nonDerivative · entry 2 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,565 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004664 · form4-05052022_010503.xml · derivative · entry 3 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,233 Underlying: Common Stock · 5,616 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On May 3, 2021, the reporting person was granted 16,849 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On May 3, 2021, the reporting person was granted 16,849 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-004664 · form4-05052022_010503.xml · nonDerivative · entry 1 Jensen Claus Torp · CIK 0001857993 · CHIEF INNOVATION OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 33,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001908 · edgar.xml · derivative · entry 1 Jensen Claus Torp · CIK 0001857993 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,688 Underlying: Common Stock · 33,688 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:40 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 16,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004905 · edgar.xml · derivative · entry 2 Jensen Claus Torp · CIK 0001857993 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,849 Underlying: Common Stock · 16,849 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:40 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 6,796 | $0.00 Strike: $163.21 | $0.00 |
DisclosureSEC source: 0001179110-21-004905 · edgar.xml · derivative · entry 1 Jensen Claus Torp · CIK 0001857993 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,796 Underlying: Common Stock · 6,796 shares Expires 2031-05-03 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the grant date. The remainder of the shares vest in 36 substantially equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.